Sharenet Sites 
Sharenet Sites
Notification of major interest in shares
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
23 February 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: Mediclinic International plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares
already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: Coronation Asset Management (Pty) Ltd
4. Full name of shareholder(s)
(if different from 3.): N/A
5. Date of the transaction and date on
which the threshold is crossed or 23 February 2017
reached:
6. Date on which issuer notified: 23 February 2017
7. Threshold(s) that is/are crossed or
reached: 3%
8. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous Resulting situation after the triggering transaction
shares to the triggering
transaction
if possible using Number Number Number Number of voting % of voting rights
the ISIN CODE of of of shares rights
Shares Voting
Rights Direct Direct Indirect Direct Indirect
GB00B8HX8Z88 21 606 841 21 606 841 22 794 561 22 794 561 3.09%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may be rights
acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of voting rights % of voting rights
instrument price date Conversion instrument refers to
period
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
22 794 561 3.09%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of the proxy holder: Coronation Asset Management (Pty) Ltd
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name: Jamie Rowland
15. Contact telephone number: +27 21 680 2000
Mediclinic’s primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South Africa
and on the NSX in Namibia.
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Date: 23/02/2017 04:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
